NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

$1.96
-0.18 (-8.41%)
(As of 04/23/2024 ET)
Today's Range
$1.94
$2.20
50-Day Range
$1.55
$4.10
52-Week Range
$0.17
$10.10
Volume
9,856 shs
Average Volume
515,543 shs
Market Capitalization
$115.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BTX stock logo

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

BTX Stock Price History

BTX Stock News Headlines

'Brooklyn Nine-Nine' star Andre Braugher dies at 61
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Brooklyn Bridge
Brooklyn Bedding Coupon for November
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Brooklyn Hospital Center
Brooklyn Technical High School
Brooklyn Preparatory High School
See More Headlines
Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Television Broadcasting
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$126.48 million
Optionable
No Data
Beta
4.61
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Matthew Angel
    President, Chief Executive Officer & Director
  • Andrew C. Jackson
    Chief Financial Officer
  • Roger Sidhu
    Chief Medical Officer
  • Jay Sial
    Chief Administrative Officer
  • Sandra Gurrola
    Principal Accounting Officer & VP-Finance

BTX Stock Analysis - Frequently Asked Questions

How have BTX shares performed in 2024?

Brooklyn ImmunoTherapeutics' stock was trading at $4.1020 at the beginning of 2024. Since then, BTX stock has decreased by 52.2% and is now trading at $1.96.
View the best growth stocks for 2024 here
.

How do I buy shares of Brooklyn ImmunoTherapeutics?

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BTX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners